China Biologic Products (CBPO) Reports Q4 EPS of $0.76/Share

China Biologic Products (NASDAQ: CBPO) reported Q4 EPS of $0.76, versus $0.90 reported last year. Revenue for the quarter came in at $114.9 million, versus $90.1 million reported last year.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15